OBJECTIVES: Upon completion of this activity, the participant should be able to:
1)  Recognize the etiology and discuss the prevalence of Tricuspid Regurgitation.
2)  Discuss the treatment strategies and research trial opportunities for tricuspid regurgitation.

FACULTY DISCLOSURE: 
Molly Szerlip, MD                                                           
Edward LifeScience - speaker/proctor/consultant fee
Boston Scientific – Honoraria/speaker
Abbott Vascular – Advisory Board
Medtronic – Steering Committee

Robert Smith, MD
Edward LifeScience – Grant support/research; consultant fee/honoraria/speaker
Medtronic – Consultant fee/honoraria/speaker
Artivion – Speaker/grant

PLANNER DISCLOSURE:  Dr. Michael Mack, MD; Jennifer Thomas, BS, MS;  Alaina Tellson PhD, RN, NPD-BC, NE-BC; and Crystal Brooks, LMSW, ACM-SW, CTP , have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

This session is not approved for Nursing CNE or Social Work
NURSES: Baylor Scott & White Health is accredited as a provider of nursing continuing professional development by the American Nurses
Credentialing Center's Commission on Accreditation.

SOCIAL WORKERS: This program meets the qualifying criteria for social work continuing education pursuant to TAC 781.509 and is directly related
to the practice of social work and is approved for 1.0 CEU- BSWH SW CE Approval ######.